Abstract P3-01-04: A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2- advanced breast cancer

Rodrigo Sánchez-Bayona, Eva Ciruelos, Alfonso López de et al.|Cancer Research|2023

Cited by 1